“Master protocol” phase III national trials that simultaneously test multiple agents were among proposals designed to streamline drug trial and approval processes that were discussed at the fifth annual Conference on Clinical Cancer Research.

©2012 American Association for Cancer Research.
2012
You do not currently have access to this content.